Cellular characterisation of Candida tropicalis presenting fluconazole-related trailing growth

Detalhes bibliográficos
Autor(a) principal: Dornelas-Ribeiro,Marcos
Data de Publicação: 2012
Outros Autores: Pinheiro,Eliane Olmo, Guerra,Carolina, Braga-Silva,Lys Adriana, Carvalho,Silvia Maia Faria de, Santos,André Luis Souza dos, Rozental,Sonia, Fracalanzza,Sergio Eduardo Longo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Memórias do Instituto Oswaldo Cruz
Texto Completo: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762012000100005
Resumo: We assessed fluconazole susceptibility in 52 Candida tropicalis clinical strains using seven antifungal susceptibility methods, including broth microdilution (BMD) [standard M27 A3 (with neutral and acid pH), ATB Fungus 3, Vitek 2 system and flow cytometric analysis] and agar-based methods (disk diffusion and E-test). Trailing growth, detection of cell-associated secreted aspartic proteases (Saps) and morphological and ultrastructural traits of these clinical strains were also examined. The ranges of fluconazole 24 h-minimum inhibitory concentration (MIC) values were similar among all methods. The essential agreement among the methods used for MIC determinations was excellent and all methods categorised all strains as susceptible, except for one strain that showed a minor error. The presence of the trailing effect was assessed by six methods. Trailing positivity was observed for 86.5-100% of the strains. The exception was the BMD-Ac method where trailing growth was not observed. Morphological and ultrastructural alterations were detected in C. tropicalis trailing cells, including mitochondrial swelling and cell walls with irregular shapes. We tested the production of Saps in 13 C. tropicalis strains expressing trailing growth through flow cytometry. Our results showed that all of the C. tropicalis strains up-regulated surface Sap expression after 24 h or 48 h of exposure to fluconazole, which was not observed in untreated yeast strains. We concluded that C. tropicalis strains expressing trailing growth presented some particular features on both biological and ultrastructural levels.
id FIOCRUZ-4_65de8cd3f4678a5ee5f798dfcf5d6f07
oai_identifier_str oai:scielo:S0074-02762012000100005
network_acronym_str FIOCRUZ-4
network_name_str Memórias do Instituto Oswaldo Cruz
spelling Cellular characterisation of Candida tropicalis presenting fluconazole-related trailing growthCandida tropicalisantifungal susceptibility testtrailing growthbiological and ultrastructural alterationsaspartic protease productionWe assessed fluconazole susceptibility in 52 Candida tropicalis clinical strains using seven antifungal susceptibility methods, including broth microdilution (BMD) [standard M27 A3 (with neutral and acid pH), ATB Fungus 3, Vitek 2 system and flow cytometric analysis] and agar-based methods (disk diffusion and E-test). Trailing growth, detection of cell-associated secreted aspartic proteases (Saps) and morphological and ultrastructural traits of these clinical strains were also examined. The ranges of fluconazole 24 h-minimum inhibitory concentration (MIC) values were similar among all methods. The essential agreement among the methods used for MIC determinations was excellent and all methods categorised all strains as susceptible, except for one strain that showed a minor error. The presence of the trailing effect was assessed by six methods. Trailing positivity was observed for 86.5-100% of the strains. The exception was the BMD-Ac method where trailing growth was not observed. Morphological and ultrastructural alterations were detected in C. tropicalis trailing cells, including mitochondrial swelling and cell walls with irregular shapes. We tested the production of Saps in 13 C. tropicalis strains expressing trailing growth through flow cytometry. Our results showed that all of the C. tropicalis strains up-regulated surface Sap expression after 24 h or 48 h of exposure to fluconazole, which was not observed in untreated yeast strains. We concluded that C. tropicalis strains expressing trailing growth presented some particular features on both biological and ultrastructural levels.Instituto Oswaldo Cruz, Ministério da Saúde2012-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762012000100005Memórias do Instituto Oswaldo Cruz v.107 n.1 2012reponame:Memórias do Instituto Oswaldo Cruzinstname:Fundação Oswaldo Cruzinstacron:FIOCRUZ10.1590/S0074-02762012000100005info:eu-repo/semantics/openAccessDornelas-Ribeiro,MarcosPinheiro,Eliane OlmoGuerra,CarolinaBraga-Silva,Lys AdrianaCarvalho,Silvia Maia Faria deSantos,André Luis Souza dosRozental,SoniaFracalanzza,Sergio Eduardo Longoeng2020-04-25T17:51:07Zhttp://www.scielo.br/oai/scielo-oai.php0074-02761678-8060opendoar:null2020-04-26 02:18:07.694Memórias do Instituto Oswaldo Cruz - Fundação Oswaldo Cruztrue
dc.title.none.fl_str_mv Cellular characterisation of Candida tropicalis presenting fluconazole-related trailing growth
title Cellular characterisation of Candida tropicalis presenting fluconazole-related trailing growth
spellingShingle Cellular characterisation of Candida tropicalis presenting fluconazole-related trailing growth
Dornelas-Ribeiro,Marcos
Candida tropicalis
antifungal susceptibility test
trailing growth
biological and ultrastructural alterations
aspartic protease production
title_short Cellular characterisation of Candida tropicalis presenting fluconazole-related trailing growth
title_full Cellular characterisation of Candida tropicalis presenting fluconazole-related trailing growth
title_fullStr Cellular characterisation of Candida tropicalis presenting fluconazole-related trailing growth
title_full_unstemmed Cellular characterisation of Candida tropicalis presenting fluconazole-related trailing growth
title_sort Cellular characterisation of Candida tropicalis presenting fluconazole-related trailing growth
author Dornelas-Ribeiro,Marcos
author_facet Dornelas-Ribeiro,Marcos
Pinheiro,Eliane Olmo
Guerra,Carolina
Braga-Silva,Lys Adriana
Carvalho,Silvia Maia Faria de
Santos,André Luis Souza dos
Rozental,Sonia
Fracalanzza,Sergio Eduardo Longo
author_role author
author2 Pinheiro,Eliane Olmo
Guerra,Carolina
Braga-Silva,Lys Adriana
Carvalho,Silvia Maia Faria de
Santos,André Luis Souza dos
Rozental,Sonia
Fracalanzza,Sergio Eduardo Longo
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Dornelas-Ribeiro,Marcos
Pinheiro,Eliane Olmo
Guerra,Carolina
Braga-Silva,Lys Adriana
Carvalho,Silvia Maia Faria de
Santos,André Luis Souza dos
Rozental,Sonia
Fracalanzza,Sergio Eduardo Longo
dc.subject.por.fl_str_mv Candida tropicalis
antifungal susceptibility test
trailing growth
biological and ultrastructural alterations
aspartic protease production
topic Candida tropicalis
antifungal susceptibility test
trailing growth
biological and ultrastructural alterations
aspartic protease production
dc.description.none.fl_txt_mv We assessed fluconazole susceptibility in 52 Candida tropicalis clinical strains using seven antifungal susceptibility methods, including broth microdilution (BMD) [standard M27 A3 (with neutral and acid pH), ATB Fungus 3, Vitek 2 system and flow cytometric analysis] and agar-based methods (disk diffusion and E-test). Trailing growth, detection of cell-associated secreted aspartic proteases (Saps) and morphological and ultrastructural traits of these clinical strains were also examined. The ranges of fluconazole 24 h-minimum inhibitory concentration (MIC) values were similar among all methods. The essential agreement among the methods used for MIC determinations was excellent and all methods categorised all strains as susceptible, except for one strain that showed a minor error. The presence of the trailing effect was assessed by six methods. Trailing positivity was observed for 86.5-100% of the strains. The exception was the BMD-Ac method where trailing growth was not observed. Morphological and ultrastructural alterations were detected in C. tropicalis trailing cells, including mitochondrial swelling and cell walls with irregular shapes. We tested the production of Saps in 13 C. tropicalis strains expressing trailing growth through flow cytometry. Our results showed that all of the C. tropicalis strains up-regulated surface Sap expression after 24 h or 48 h of exposure to fluconazole, which was not observed in untreated yeast strains. We concluded that C. tropicalis strains expressing trailing growth presented some particular features on both biological and ultrastructural levels.
description We assessed fluconazole susceptibility in 52 Candida tropicalis clinical strains using seven antifungal susceptibility methods, including broth microdilution (BMD) [standard M27 A3 (with neutral and acid pH), ATB Fungus 3, Vitek 2 system and flow cytometric analysis] and agar-based methods (disk diffusion and E-test). Trailing growth, detection of cell-associated secreted aspartic proteases (Saps) and morphological and ultrastructural traits of these clinical strains were also examined. The ranges of fluconazole 24 h-minimum inhibitory concentration (MIC) values were similar among all methods. The essential agreement among the methods used for MIC determinations was excellent and all methods categorised all strains as susceptible, except for one strain that showed a minor error. The presence of the trailing effect was assessed by six methods. Trailing positivity was observed for 86.5-100% of the strains. The exception was the BMD-Ac method where trailing growth was not observed. Morphological and ultrastructural alterations were detected in C. tropicalis trailing cells, including mitochondrial swelling and cell walls with irregular shapes. We tested the production of Saps in 13 C. tropicalis strains expressing trailing growth through flow cytometry. Our results showed that all of the C. tropicalis strains up-regulated surface Sap expression after 24 h or 48 h of exposure to fluconazole, which was not observed in untreated yeast strains. We concluded that C. tropicalis strains expressing trailing growth presented some particular features on both biological and ultrastructural levels.
publishDate 2012
dc.date.none.fl_str_mv 2012-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762012000100005
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762012000100005
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0074-02762012000100005
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Instituto Oswaldo Cruz, Ministério da Saúde
publisher.none.fl_str_mv Instituto Oswaldo Cruz, Ministério da Saúde
dc.source.none.fl_str_mv Memórias do Instituto Oswaldo Cruz v.107 n.1 2012
reponame:Memórias do Instituto Oswaldo Cruz
instname:Fundação Oswaldo Cruz
instacron:FIOCRUZ
reponame_str Memórias do Instituto Oswaldo Cruz
collection Memórias do Instituto Oswaldo Cruz
instname_str Fundação Oswaldo Cruz
instacron_str FIOCRUZ
institution FIOCRUZ
repository.name.fl_str_mv Memórias do Instituto Oswaldo Cruz - Fundação Oswaldo Cruz
repository.mail.fl_str_mv
_version_ 1669937711036760064